bpc 157 hims BPC-157 PURE Delayed Release Confirmed: The FDA just moved
Confirmed: The FDA just moved BPC 157 one step closer to compounded access. This could unleash an entirely new revenue stream. $HIMS BPC 157 Mark Hyman, MD BPC 157 Alphaceuticals by Dr. Catherine HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



